4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001104659-14-019715
CIK 0001373707operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 2:43 PM ET
Size
11.8 KB
Accession
0001104659-14-019715
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2014-03-12+4,493→ 4,493 total(indirect: By LLC) - Other
Common Stock
2014-03-12−300,000→ 1,890,146 total(indirect: See footnote)
Footnotes (2)
- [F1]Represents a pro-rata in-kind distribution by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. ("SVP IV") without consideration to its limited and general partners.
- [F2]The shares are held by SVP IV. John G. Freund, M.D. and Yasunori Kaneko, M.D. are the Managing Members of Skyline Venture Management IV, LLC, the general partner of SVP IV, and may be deemed to share voting and dispositive power over the shares held by SVP IV. Stephen Hoffman, M.D., Ph.D. is a member of Skyline Venture Management IV, LLC and may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by SVP IV. Each of Dr. Freund and Mr. Hoffman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Dr. Freund is a director of the Issuer and, accordingly, files separate Section 16 reports.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 2:43 PM ET
- Size
- 11.8 KB